Cargando…

Postradiation Histiocytic Sarcoma in the Setting of Muir-Torre Syndrome

Hereditary nonpolyposis colorectal carcinoma (HNPCC) is an autosomal dominant genetic disorder characterized by a predisposition towards colorectal carcinoma and other extracolonic neoplasms. Histiocytic sarcoma (HS) is a very rare hematologic neoplasm characterized by a malignant proliferation of c...

Descripción completa

Detalles Bibliográficos
Autores principales: Baumgartner, Erin, Ullman, David, Jones, Jeffrey Adam, Fasciano, Danielle, Atherton, Daniel S., Pavlidakey, Peter, Peker, Deniz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5941799/
https://www.ncbi.nlm.nih.gov/pubmed/29850341
http://dx.doi.org/10.1155/2018/5947870
_version_ 1783321358439022592
author Baumgartner, Erin
Ullman, David
Jones, Jeffrey Adam
Fasciano, Danielle
Atherton, Daniel S.
Pavlidakey, Peter
Peker, Deniz
author_facet Baumgartner, Erin
Ullman, David
Jones, Jeffrey Adam
Fasciano, Danielle
Atherton, Daniel S.
Pavlidakey, Peter
Peker, Deniz
author_sort Baumgartner, Erin
collection PubMed
description Hereditary nonpolyposis colorectal carcinoma (HNPCC) is an autosomal dominant genetic disorder characterized by a predisposition towards colorectal carcinoma and other extracolonic neoplasms. Histiocytic sarcoma (HS) is a very rare hematologic neoplasm characterized by a malignant proliferation of cells with histiocytic differentiation. We present the case of a 62-year-old male with previous diagnosis of MTS who presented with metastatic colorectal adenocarcinoma, bilateral papillary renal cell carcinoma, and a new squamous cell carcinoma of the scalp, treated with resection and adjuvant radiation therapy. After reconstructive surgery for his scalp resection, the patient developed a persistent nonhealing skin defect. A punch biopsy of this nonhealing skin defect and subsequent immunohistochemistry revealed neoplastic histiocytic cells restricted to the epidermis and underlying dermis. The diagnosis of cutaneous histiocytic sarcoma was then rendered. Histiocytic sarcoma is an exceptionally rare malignancy. Consequently, there is no universally agreed upon management protocol for this malignancy. The patient was admitted to hospice and treated with palliative radiation. This case demonstrates the need for awareness of the risk of secondary malignancies in cancer patients in order to facilitate early surgical intervention and optimal treatment.
format Online
Article
Text
id pubmed-5941799
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-59417992018-05-30 Postradiation Histiocytic Sarcoma in the Setting of Muir-Torre Syndrome Baumgartner, Erin Ullman, David Jones, Jeffrey Adam Fasciano, Danielle Atherton, Daniel S. Pavlidakey, Peter Peker, Deniz Case Rep Pathol Case Report Hereditary nonpolyposis colorectal carcinoma (HNPCC) is an autosomal dominant genetic disorder characterized by a predisposition towards colorectal carcinoma and other extracolonic neoplasms. Histiocytic sarcoma (HS) is a very rare hematologic neoplasm characterized by a malignant proliferation of cells with histiocytic differentiation. We present the case of a 62-year-old male with previous diagnosis of MTS who presented with metastatic colorectal adenocarcinoma, bilateral papillary renal cell carcinoma, and a new squamous cell carcinoma of the scalp, treated with resection and adjuvant radiation therapy. After reconstructive surgery for his scalp resection, the patient developed a persistent nonhealing skin defect. A punch biopsy of this nonhealing skin defect and subsequent immunohistochemistry revealed neoplastic histiocytic cells restricted to the epidermis and underlying dermis. The diagnosis of cutaneous histiocytic sarcoma was then rendered. Histiocytic sarcoma is an exceptionally rare malignancy. Consequently, there is no universally agreed upon management protocol for this malignancy. The patient was admitted to hospice and treated with palliative radiation. This case demonstrates the need for awareness of the risk of secondary malignancies in cancer patients in order to facilitate early surgical intervention and optimal treatment. Hindawi 2018-04-24 /pmc/articles/PMC5941799/ /pubmed/29850341 http://dx.doi.org/10.1155/2018/5947870 Text en Copyright © 2018 Erin Baumgartner et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Baumgartner, Erin
Ullman, David
Jones, Jeffrey Adam
Fasciano, Danielle
Atherton, Daniel S.
Pavlidakey, Peter
Peker, Deniz
Postradiation Histiocytic Sarcoma in the Setting of Muir-Torre Syndrome
title Postradiation Histiocytic Sarcoma in the Setting of Muir-Torre Syndrome
title_full Postradiation Histiocytic Sarcoma in the Setting of Muir-Torre Syndrome
title_fullStr Postradiation Histiocytic Sarcoma in the Setting of Muir-Torre Syndrome
title_full_unstemmed Postradiation Histiocytic Sarcoma in the Setting of Muir-Torre Syndrome
title_short Postradiation Histiocytic Sarcoma in the Setting of Muir-Torre Syndrome
title_sort postradiation histiocytic sarcoma in the setting of muir-torre syndrome
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5941799/
https://www.ncbi.nlm.nih.gov/pubmed/29850341
http://dx.doi.org/10.1155/2018/5947870
work_keys_str_mv AT baumgartnererin postradiationhistiocyticsarcomainthesettingofmuirtorresyndrome
AT ullmandavid postradiationhistiocyticsarcomainthesettingofmuirtorresyndrome
AT jonesjeffreyadam postradiationhistiocyticsarcomainthesettingofmuirtorresyndrome
AT fascianodanielle postradiationhistiocyticsarcomainthesettingofmuirtorresyndrome
AT athertondaniels postradiationhistiocyticsarcomainthesettingofmuirtorresyndrome
AT pavlidakeypeter postradiationhistiocyticsarcomainthesettingofmuirtorresyndrome
AT pekerdeniz postradiationhistiocyticsarcomainthesettingofmuirtorresyndrome